Cambridge Nutritional Sciences PLCLSE: CNSL

End of offer period

· Issued by Cambridge Nutritional Sciences PLC
Read the transcript of Cambridge Nutritional Sciences (LSE:CNSL) — Final Results
Cambridge Nutritional Sciences' next earnings callCambridge Nutritional Sciences (LSE:CNSL) — Half Year results for the six months ended 30 September 2026 · Nov 10, 2026 at 9:00 AM ESTRegister
RNS Number : 1865B
Omega Diagnostics Group PLC
21 October 2009
 

Omega Diagnostics plc

("Omega" or the "Company")

End of Offer Period

On 19 October 2009, in response to a movement in the Company's share price, the Board of Omega announced that it had received a preliminary approach from a third party in relation to a business combination that may have resulted in an offer for the Company. 

The Board today announces that discussions have now been terminated and that the third party has acknowledged that it is no longer considering an offer for the Company.  Accordingly, the company has ceased to be in an "offer period" for the purposes of the City Code on Takeovers and Mergers.

Contact:

Omega Diagnostics Group PLC  

Tel: 01259 763 030

Andrew Shepherd, Chief Executive  

Kieron Harbinson, Group Finance Director  

www.omegadiagnostics.com

Cenkos Securities plc  

Tel: 020 7397 8900

Nicholas Wells

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8780

Ben Knowles

Paul McManus

[email protected]

Mob: 07900 346978

[email protected]

Mob: 07980 541893

.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OTTEASEFALKNFFE

Cambridge Nutritional Sciences PLC on 6ix

Earlier from Cambridge Nutritional Sciences

Later from Cambridge Nutritional Sciences

All Cambridge Nutritional Sciences news releases